The Pulmonary Injury and Repair Center at the University of Alabama at Birmingham has produced a major return on investment in its six years of existence. The Center, begun in 2008 with an initial investment of $140,000 from the UAB School of Medicine, Department of Anesthesiology and Southern Research Institute, has since received nearly $10 million in research funding from government and industry sources.
Those funds have spurred scientific research, recruited new faculty and produced new knowledge in treating lung injury, especially from chemical agents such as chlorine, ammonia and bromine.
Chlorine, ammonia and bromine are commonly used in various industrial applications and are routinely shipped across the country. Exposure to these agents could come as a result of a deliberate terror attack or from an inadvertent leak from a transportation mishap.
“Inhalation of these gases can cause extreme, possibly fatal injury to the lungs,” said Sadis Matalon, Ph.D., distinguished professor and vice chair for research in the Department of Anesthesiology, and director of the center. “Our research is geared toward finding countermeasures that could be employed to minimize pulmonary injury in the event of a chlorine, ammonia or bromine release, whatever the cause may be.”
The UAB center is part of the federal government’s CounterACT Program. Funded by the National Institutes of Health, CounterACT is a translational research program aimed at the discovery and/or identification of better therapeutic medical countermeasures and technologies against chemical threat agents. CounterACT was launched following the terror attacks on Sept. 11, 2001, as awareness grew of potential threats from chemical agents.
UAB is one of the few research institutions in the nation involved in countermeasure research against chlorine and ammonia, and it is the only site looking for agents that would be effective against bromine, according to Matalon.
“We are investigating multiple strategies to respond to lung injury in the event of exposure to these agents,” Matalon said. “We have identified compounds that in preliminary studies have been shown to prevent death after chlorine exposure, for example. Compounds such as antioxidants and nitrites also have promise in reducing or reversing the toxic effects of these agents.”
Matalon says one of the center’s strengths is its reach across the breadth of UAB. Investigators involved in the major projects come from multiple disciplines and include Victor Darley-Usmar, Ph.D., and Jianhua Zhang, Ph.D., pathology; Tim Ness, M.D., anesthesiology; Chad Steele, Ph.D., and Veena Antony, M.D., pulmonary medicine; Rakesh Patel, Ph.D., molecular and cellular pathology; Mohammad Athar, dermatology; and Anupam Agarwal, M.D., nephrology. Other prominent investigators include Edward Postlethwait, Ph.D., Michelle Fanucchi, Ph.D., and Giuseppe Squadrito, Ph.D., in the School of Public Health; as well as James and Diana Noah, Ph.D.s, with Southern Research Institute.
Matalon and Darley-Usmar received a grant to test the role of mitochondrial injury in the initiation and propagation of chlorine injury to the lungs. Matalon is also collaborating with Sven Eric Jordt, Ph.D., of Yale University, to test the effectiveness of a new class of anti-inflammatory agents to decrease chlorine injury.
Patel was recently funded by the CounterACT Program to test the efficacy of nitrites to decrease mortality and lung injury in chlorine-exposed animals. Athar is funded by CounterACT to develop therapeutic interventions of lewisite-mediated injury to the skin, which could contribute to lung injury. Ness was also funded to investigate whether local anesthetics administered post-exposure reduce pain.
“This is a critical issue because people who experience pain have decreased ability to walk away from the epicenter of a chemical attack,” Matalon said.
The center also played a role in the recruitment of prominent new faculty to UAB, says Matalon, including Victor Thannickal, M.D., chair of the Division of Pulmonary, Allergy and Critical Care Medicine, and Jean-Francois Pittet, M.D., professor of anesthesiology.
“The Pulmonary Injury and Repair Center has enhanced collaborations among basic and clinical investigators at UAB and has driven translational research in lung injury and repair,” Matalon said. “It has also strengthened existing interactions among researchers from UAB and Southern Research Institute. These interactions continue to improve our ability to attract new faculty interested in pulmonary research at UAB and to compete for extramural awards.”
UAB Engineering award-winning team works with NASA to bring high-tech freezers to spaceUAB’s Engineering and Innovative Technology Development team will be recognized by NASA for achievement in space-related research and production.posted 3 days ago 1757 viewsUAB ranked among the world’s top 150 again by Center for World University RankingsUAB has been ranked No. 1 in Alabama and among the top 150 universities in the world by the Center for World University Rankings.posted 3 days ago 4448 viewsUAB optometrist improves treatment and care for patients with dry eyeIndividuals with dry eye have hope as researchers continue to learn more about causes, symptoms and treatments.posted 3 days ago 536 viewsTechnology improves clinical trial management and patient experienceUAB has implemented a new application suite to improve clinical trial management, and enhance communication among trial sites and with study participants.posted 4 days ago 505 viewsDiscovery may lead to a treatment to slow Parkinson’s diseaseResearchers have found that an interaction between a mutant gene and alpha synuclein in neurons leads to hallmark pathologies seen in Parkinson’s disease, findings that may lead to new mechanisms and targets for neuroprotection.posted 5 days ago 10799 viewsNIH awards UAB three maternal and infant health grantsUAB continues to improve maternal and infant health as the only university to be a member of all three NIH perinatal networks.posted 5 days ago 775 viewsThe zebrafish’s growing impact on medical researchThe zebrafish is making its mark in the field of biomedical research, becoming one of the fastest-growing models of human disease.posted 5 days ago 537 viewsChronic fatigue syndrome flare-ups caused by straining muscles and nervesMild to moderate muscle and nerve strain provokes symptom flares in individuals with chronic fatigue syndrome.posted 6 days ago 4385 viewsCheckpoint in B cell development discovered with possible implications on vaccine potencyA quality-control checkpoint in pre-B cells restricts the range of antibodies produced by mature B cells, and manipulation of the checkpoint could make vaccines more potent.posted 6 days ago 902 viewsUAB researchers awarded $11.5 million to study asymptomatic congenital CMV and neonatal HSVThe NIH recently awarded UAB $11.5 million to support studies that will assess treatment of babies born with congenital cytomegalovirus but no symptoms, and frequency of neonatal herpes infections in the United States and Peru.posted 10 days ago 4199 viewsUAB researcher receives funding for rheumatology studyA pilot grant was recently awarded to UAB to investigate a noninvasive method of detecting neuroinflammation in rheumatoid arthritis.posted 11 days ago 1495 viewsPioneer of high-technology cancer surgery will lecture at UAB on July 19The iKnife, a revolutionary mass spectrometry method, contributes to precision surgery by allowing accurate identification of cancer margins.
Nation’s first joint OD/MBA degree program opens at UABDual degree will prepare graduates to pursue clinical and administrative career opportunities in the eye care field.posted 13 days ago 1921 viewsNew UAB online bachelor’s program addresses rising demand for distribution professionalsA flexible, 100 percent online-based program will blend engineering and business curricula to prepare students for the growing industrial distribution industry.posted 16 days ago 1872 viewsUAB ECMO program wins goldUAB’s program for extracorporeal membrane oxygenation, or ECMO, has won a Gold Level Award for Excellence.posted 17 days ago 7867 viewsExtra-coding RNAs regulate DNA methylation in the adult brainThe ecRNAs appear to act in memory formation, and may offer a new therapeutic approach to neuropsychiatric diseases.posted 17 days ago 1716 viewsHudsonAlpha and UAB awarded NIH training grantThe program is the first of its kind to incorporate research and medical training in genomics.posted 18 days ago 1522 viewsParkinson’s disease biomarker found in patient urine samplesThe biomarker, the protein kinase LRRK2, is a promising candidate for future exploration.posted 19 days ago 3914 viewsUAB study showcases poisoning risk to small children from laundry podsUAB study says laundry pod detergents pose an increased risk of severe injury for young children over nonpod detergents.posted a while back 2644 viewsAn Antarctic sponge offers new hope against deadly MRSA infectionA potent compound discovered by UAB researchers in Antarctic waters could be a new weapon against a bacterial infection that kills thousands each year.posted a while back 9033 views
- Event Date July 19